An assessment of false discovery rates and statistical significance in label-free quantitative proteomics with combined filters by Li, Qingbo & Roxas, Bryan AP
BioMed  Central
Page 1 of 18
(page number not for citation purposes)
BMC Bioinformatics
Open Access Methodology article
An assessment of false discovery rates and statistical significance in 
label-free quantitative proteomics with combined filters
Qingbo Li*1,2 and Bryan AP Roxas1
Address: 1Center for Pharmaceutical Biotechnology, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60607, USA and 
2Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA
Email: Qingbo Li* - qkli@uic.edu; Bryan AP Roxas - baproxas@uic.edu
* Corresponding author    
Abstract
Background: Many studies have provided algorithms or methods to assess a statistical significance
in quantitative proteomics when multiple replicates for a protein sample and a LC/MS analysis are
available. But, confidence is still lacking in using datasets for a biological interpretation without
protein sample replicates. Although a fold-change is a conventional threshold that can be used when
there are no sample replicates, it does not provide an assessment of statistical significance such as
a false discovery rate (FDR) which is an important indicator of the reliability to identify differentially
expressed proteins. In this work, we investigate whether differentially expressed proteins can be
detected with a statistical significance from a pair of unlabeled protein samples without replicates
and with only duplicate LC/MS injections per sample. A FDR is used to gauge the statistical
significance of the differentially expressed proteins.
Results: We have experimented to operate on several parameters to control a FDR, including a
fold-change, a statistical test, and a minimum number of permuted significant pairings. Although
none of these parameters alone gives a satisfactory control of a FDR, we find that a combination
of these parameters provides a very effective means to control a FDR without compromising the
sensitivity. The results suggest that it is possible to perform a significance analysis without protein
sample replicates. Only duplicate LC/MS injections per sample are needed. We illustrate that
differentially expressed proteins can be detected with a FDR between 0 and 15% at a positive rate
of 4–16%. The method is evaluated for its sensitivity and specificity by a ROC analysis, and is further
validated with a [15N]-labeled internal-standard protein sample and additional unlabeled protein
sample replicates.
Conclusion: We demonstrate that a statistical significance can be inferred without protein sample
replicates in label-free quantitative proteomics. The approach described in this study would be
useful in many exploratory experiments where a sample amount or instrument time is limited.
Naturally, this method is also suitable for proteomics experiments where multiple sample
replicates are available. It is simple, and is complementary to other more sophisticated algorithms
that are not designed for dealing with a small number of sample replicates.
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Background
High-resolution mass spectrometry instruments coupled
with separation techniques are widely used to quantify
hundreds to over a thousand proteins in complex biolog-
ical samples. Inevitably, quantitative proteomics on such
a large scale encounters a similar statistical data-analysis
challenge seen in a DNA microarray. Whereas algorithms
for solving significance analysis problems in microarray
data have been extensively explored, as recently reviewed
[1-3], substantial efforts are still required for a statistical
analysis of quantitative datasets in proteomics experi-
ments [4,5]. Many groups have attempted to develop a
new or to adapt an existing statistical analysis method in
a microarray analysis for data analysis in quantitative pro-
teomics [6-9].
With a 2-D DIGE technique and an ANOVA statistical
analysis method, Corzett et al. [10] examined the varia-
tion among eight technical replicates of a human plasma
sample, and suggested that four biological replicates were
required to detect a 2-fold change. For LC/MS shotgun
proteomics, Pavelka et al. [9] demonstrated that normal-
ized spectral abundance factor (NSAF) values in proteom-
ics data shared a substantial similarity with
transcriptomics data, and that the power law global error
model (PLGEM) originally developed for a microarray
data analysis [11] could be used for analyzing NSAF data-
sets in quantitative proteomics. The PLGEM-STN method,
which required a minimum of 4 replicates to operate, was
hence used in place of a conventional t-test. This body of
work "lays the foundation for the application of microar-
ray-specific tools in the analysis of NSAF datasets" [9].
Choi et al. [8] developed a new statistical framework
(QSpec) based on a hierarchical Bayes statistical method-
ology to discern differentially expressed proteins using
NSAF data with or without replicates. The method builds
upon the likelihood ratio of two competing statistical
models; one with and the other without the term for treat-
ment effect (relative to control) in a generalized linear
mixed model. A large likelihood ratio between these two
statistical models indicates that a protein is differentially
expressed. It was concluded that the QSpec method [8]
outperformed the PLGEM-STN method [9]. We previ-
ously used the Significance Analysis for Microarray (SAM)
method to perform a significance analysis of two samples
with triplicates for quantitative proteomics in comparison
with a conventional t-test and a fold-change method [6].
The SAM method provides richer statistical information
for gauging the confidence of the results, but requires
multiple replicates to perform.
The QSpec method [8] was for data generated by the spec-
tral count method [12]. The spectral count method has
become an accepted method for label-free quantitation in
proteomics [5], was compared favorably to measurements
of extracted ion-chromatographic intensities [13], and
was shown to bear quantitative characteristics similar to
gene data in transcriptomics [9]. While the spectral count
method has the advantage of being applicable towards
shotgun proteomics data using medium or even low reso-
lution mass spectrometers, comparison of proteins
between two conditions is restricted to only those that are
identified by MS/MS scans in both conditions. This
restriction would severely limit the number of quantifia-
ble proteins especially at low LC/MS replicates because of
the time required to dissociate the peptides individually
[14]. In addition, different peptides may be identified by
MS/MS scans for the same protein in two conditions.
Because different peptides from the same protein might
have different sensitivity, comparing the summed spectral
counts from different sets of peptides of a protein in two
conditions might compromise quantitation accuracy,
especially when the spectral counts are small.
Lipton et al. [15] introduced the concept of accurate mass
and elution time peptide tag for global protein quantita-
tion using high resolution mass spectrometry. The advan-
tage of this method over the spectral count method is that
a large number of identifications in one LC/MS injection
can be used as the basis for improved quantitation of
another LC/MS injection [14,16,17]. The accurate mass
and elution time peptide tag approach uses the extracted
ion-chromatographic intensities as the quantitative meas-
urement of peptides and proteins. The linear response of
peptide extracted ion-chromatographic intensities to pro-
tein quantities has been demonstrated [18-20]. We have
used this method to improve the comparability of pro-
teins quantified between samples and among LC/MS
injections [21].
Despite the demonstrated similarity between proteomics
and transcriptomics data, and the promise of adapting
many of the statistical tools originally developed for a
microarray to analyze quantitative proteomics data [6,9],
there are still some fundamental differences between the
two types of data that require a specific attention when
analyzing proteomics data.
One difference is that detecting differences in individual
proteins depends on the number of peptides detected for
each protein. This complicates the statistical models that
can be applied. This issue is minor in microarray data
because the number of probes for each gene is usually the
same. Thus, microarray data analysis tools usually are not
designed to accommodate a large difference in probe
numbers for genes in the same array. When we applied
SAM for a significance analysis in proteomics in the previ-
ous study [6], we simplified the scenario by using only
protein-level replicates for the SAM analysis. This howeverBMC Bioinformatics 2009, 10:43 http://www.biomedcentral.com/1471-2105/10/43
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was done without utilizing the full information in LC/MS
data, which would be a limitation when there is a paucity
of replicates. Choi et al. [8] also stressed that "the techni-
cal challenges for modeling quantitative proteomics data
are distinct in their own right". The difficulty of modeling
LC/MS data in proteomics increases "the burden of find-
ing the appropriate statistical model and estimation
methods " [8].
Another issue is the practicability of routinely obtaining
as many replicate analyses as in a microarray analysis. This
has to do with the throughput of a proteomics analysis.
Bottom-up quantitative proteomics for complex samples
normally requires a fractionation process for samples, and
takes many LC/MS runs. A LC/MS run can take up to a
couple of hours. Thus, LC/MS remains a relatively low-
throughput methodology compared to a gene microarray
analysis. In a gene microarray analysis, once a microarray
chip is decided, a replicate analysis can be scaled up much
faster. In LC/MS based quantitative proteomics, however,
each replicate analysis consumes approximately the same
amount of time and resources. This LC/MS instrument
availability issue sometimes is further confounded by the
limited amount of sample materials. Thus, "comparative
profiling of two or more distinct biological conditions is
rarely performed in sufficient number of replicates or
samples" [8]. Many proteomics analyses were performed
with less than three replicates.
Therefore, there is a strong motivation to establish a sig-
nificance analysis method that provides an estimation of
false discovery rate (FDR) where the number of replicates
for a sample or a LC/MS injection is smaller than three. An
extreme scenario is that two samples under comparison
do not have replicates. Although this seems atypical for a
statistical analysis, it is common in many routine pro-
teomics studies for different reasons. For example, there
may be a constraint of available sample materials. There
may not be enough instrument time or resources to run
many sample replicates. Sometimes biological experi-
ments generate many biological replicates that place too
much of a burden to run all the replicates individually and
thoroughly. An obvious option is to take an average of the
multiple biological replicates by pooling them together
before analysis. This however eliminates the sample mul-
tiplicity. Therefore, an approach capable of providing a
statistical assessment of protein quantitation results will
be important for routine quantitative proteomics studies
in which sample replicates are not readily available.
In this study, we develop an approach to perform a statis-
tical analysis of two protein samples using label-free
quantitative proteomics without protein sample repli-
cates.
Results and discussion
The purpose of this work is to establish a simple method
for significance analysis in label-free quantitative pro-
teomics without protein sample replicates. The protein
quantitation was based on extracted ion-chromatographic
intensities and accurate mass and elution-time peptide-
tags. We used a FDR as an indicator of statistical signifi-
cance for differentially expressed proteins. A FDR is the
ratio between the number of false positives and the
number of positives.
Since its introduction by Benjamini and Hochberg [22],
the concept of FDR has been widely used. Many large scale
data analyses in genomics and proteomics studies use this
concept to solve the significance analysis problem [23-
25]. While several variations of the FDR method were later
introduced, the original one shows the best control of
FDR at the target level [23]. In this study, we adapt the
original FDR definition, which is the expected rate of erro-
neous rejection of hypothesis among the total rejected
hypothesis [22].
For the sample model in this study, we are interested in
identifying the proteins differentially expressed in an
acidic M. smegmatis cell culture (S) versus a neutral pH M.
smegmatis cell culture (R) (see Methods). For the purpose
to assess FDR, we [15N]-labeled a culture sample and used
it as an internal standard (IS). This IS sample was spiked
into the unlabeled samples S and R to run concurrently.
In this study, the positives are the proteins claimed as dif-
ferentially expressed between the samples S and R with
specific criteria. Any protein from the IS sample must be a
positive if it is found differentially expressed between the
two identical IS samples run concurrently with the S and
R samples. Hence, a FDR can be explicitly expressed as the
ratio of the number of differentially expressed proteins
between the two identical IS samples run concurrently
with the samples S and R over that between the samples S
and R.
There are different options to determine positives from
the samples S and R and false positives from the sample
IS. The simplest way is to use a fold-change cutoff. But it
has been shown to lack a specificity without an additional
statistical test [6]. We determined that a statistical test
such as the t-test or the Wilcoxon ranksum test was neces-
sary. In this study, the t-test or the Wilcoxon ranksum test
was performed at the peptide level instead of at the pro-
tein level [6]. Such a statistical test does not require sam-
ple replicates. The basis of the statistical test is the
following. When a protein was quantified with a common
set of peptide charge states (PCSs) between the samples S
and R, the multiple PCSs represented replicate measure-
ments of the protein in the samples S and R. This allows aBMC Bioinformatics 2009, 10:43 http://www.biomedcentral.com/1471-2105/10/43
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statistical test of the protein abundance difference
between the two samples. However, our initial test sug-
gested that the combination of fold change and a statisti-
cal test was still not stringent enough to provide desired
specificity when there were no protein sample replicates.
To solve this problem, we introduce the concept of a 'min-
imum number of permuted significant pairings' (MPSP).
The rationale behind the concept of MPSP is straightfor-
ward. For the samples S and R, each sample is run twice
with LC/MS. The permutation of the duplicate LC/MS
injections between these two samples generates four sam-
ple-pairings. Each sample-pairing represents a replicate
measurement of protein abundance difference between
the samples S and R. We hypothesize that a protein bears
more statistical significance if the protein abundance dif-
ference is tested significant in all four permuted sample-
pairings. The proteins claimed significant in fewer per-
muted sample-pairings would be less reliable. In other
words, the statistical significance of a differentially
expressed protein is related to the number of permuted
sample-pairings in which the protein meets the fold-
change threshold and is found significant by a statistical
test.
Therefore, we propose to use the combination of three cri-
teria to determine the differentially expressed proteins.
The first criterion is fold-change. The second is a statistical
test i.e., the t-test or the Wilcoxon ranksum test. The third
is a MPSP. A protein can be claimed as differentially
expressed only when it meets the three criteria: a) above a
fold-change threshold; b) tested significant by a statistical
test; c) found significant by both a) and b) in at least a
required number of permuted sample-pairings i.e., MPSP.
In the following, we describe the procedures to evaluate
the statistical significance of differentially expressed pro-
teins found between the unlabeled samples S and R with-
out replicates. We calculated a global FDR to gauge the
statistical significance using the IS sample as a control.
The method is validated with comparison of several sam-
ple combinations.
Samples
To calculate a FDR, the sample preparation has two
requirements: a) to spike the unlabeled (UL) samples S
and R with the IS sample; b) to perform duplicate LC/MS
injections per resultant sample mixture.
The procedures to generate and analyze the protein sam-
ples for an assessment of FDRs with label-free quantitative
proteomics are summarized in Figure 1. The procedures
are divided into six stages (see Methods for detailed
description).
Briefly, equal amounts of protein extract from the S cul-
ture triplicates were pooled. Equal amounts of protein
extract from the R culture triplicates were also pooled.
Into these two pooled UL protein samples, an equal
amount of protein extract from the IS culture was added.
This resulted in the two pooled samples, SP and RP (Figure
1). SP was the pooled protein extracts from the S culture
triplicates plus the IS protein extract. RP was the pooled
protein extracts from the R culture triplicates plus the IS
protein extract. In addition, the protein extracts of the S
culture triplicates were also individually spiked with an
equal amount of the IS protein extract. This resulted in
three additional protein samples, which were named SA,
SB, and SC. A total of five proteins samples i.e., SP, RP, SA,
SB, and SC, were prepared for LC/MS analysis.
The goal of the analysis was to determine the proteins dif-
ferentially expressed between the cultures S and R. We
determined the proteins differentially expressed between
the S and R cultures based on a quantitation and a com-
parison of the UL proteins between the pooled protein
samples SP and RP. For the purpose of a FDR assessment,
the IS proteins were quantified and compared between SP
and RP in the same way as the UL proteins.
The other three protein samples i.e., SA, SB, and SC, were
analyzed with LC/MS in the same way as SP and RP. SA, SB,
and SC were not considered as replicates of SP. Instead, we
used SA, SB, and SC to independently validate the results
for SP and RP. This is discussed later under the subheading
Validation.
It is important to note that each protein was quantified
with the label-free quantitation method in two isotopic
forms; one corresponds to the unlabeled (or UL) form
from the S and R cultures, and the other corresponds to
the [15N]-labeled (or IS) form from the IS culture. The pro-
teins found differentially expressed in the UL form were
considered positives, because they reflected the protein
abundance difference between the S and R cultures. The
proteins found differentially expressed in the IS form were
false positives, because difference was not expected from
the identical IS sample that was run concurrently with two
UL samples in separate runs.
Label-free quantitation
After a database search to identify peptides and proteins
with BioWorks (see Methods), a quantitation of peptides
and proteins was carried out as previously described [21].
In each sample, proteins in either the UL or the IS form
were quantified independently. Within this context, the
term 'label-free quantitation' refers to the method of
quantifying relative abundance of a protein in the same
isotopic form between two samples [16,19,26], regardless
of whether the proteins were labeled or unlabeled.BMC Bioinformatics 2009, 10:43 http://www.biomedcentral.com/1471-2105/10/43
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Operation flowchart of protein sample preparation and LC/MS analysis Figure 1
Operation flowchart of protein sample preparation and LC/MS analysis. See Methods.
(I) Cell culturing 
A B C A
S IS
A B C
R
A B C pooled pooled
SA SB SC SP RP
(II) Protein extraction
(III) LC/MS samples
SP,1 SP,2 RP,1 RP,2
For validation (see text)
(IV) LC/MS injections 
(1)
SP,1/ RP,1
(2)
SP,1/ RP,2
(V) Permuted sample parings
RA1,
UL
RA2,
UL
RA3,
UL
RA4,
UL
RA1,
IS
RA2,
IS
RA3,
IS
RA4,
IS
For determining positives For determining false positives
(VI) Positives and false positives 
(3)
SP,2/ RP,1
(4)
SP,2/ RP,2
Operation 
flowchart
Samples or analysesBMC Bioinformatics 2009, 10:43 http://www.biomedcentral.com/1471-2105/10/43
Page 6 of 18
(page number not for citation purposes)
Isotopologue profiles
For each PCS [27], two isotopologue profiles [21,28] were
present. One corresponded to the UL form and the other
to the IS form. The abundance of each isotopomer in an
isotopologue was estimated by the extracted ion-chroma-
tographic intensity of that isotopomer integrated over a
1.5-min window in the LC elution-time dimension and
the full width of the isotopomer peak in the m/z dimen-
sion, as previously described [21]. This time window was
selected based on the average peak width at half height
which was about 0.5 min. Since not all of the peaks were
symmetrical at the base, a 1.5-min time window was set to
accommodate the variation. In the strategy of accurate
mass and elution-time peptide-tags for label-free quanti-
tation, the method has been well-illustrated to estimate a
peptide abundance with the integration of the ion inten-
sities over a space defined by the m/z dimension and the
LC elution-time dimension [29]. The abundance of a PCS
was estimated with the summed extracted ion-chromato-
graphic intensities from the isotopomers under a specified
isotopologue profile. We use AUL,PCS and AIS,PCS to denote
the abundance of a PCS in its UL and IS forms respec-
tively. Similarly, we use AUL and AIS to denote the abun-
dance of a protein in its UL and IS forms respectively.
Label-free quantitation of a PCS abundance
In order to compare AUL,PCS and AIS,PCS between samples
with the label-free quantitation method, we first com-
puted the normalized AUL,PCS and AIS,PCS in the samples.
To do so, we first aligned the base-peak intensity chroma-
tograms of pairs of injections as previously described [21].
Two examples of chromatogram alignment are shown in
Figure 2. The injection RP,1 was designated as the 'raw
trace' from which AUL,PCS, and AIS,PCS were calculated. In
Figure 2A, the injection RP,2 was designated as the 'pair
trace' from which the PCSs to be quantified in RP,1 were
assigned based on the database search results for RP,2. For
alignment, the gray PCS markers were used to determine
the fitting functions of linear compression or extension
[16]. The fitting functions were used to align the RP,2 trace
against the RP,1 trace. The black PCS markers represent the
PCS markers after the time normalization. The alignment
allowed quantitation of a PCS identified by MS/MS in RP,2
but not in RP,1 [21]. Similar label-free quantitation meth-
odologies have also been well-documented by many oth-
ers [14,16,17,19,26]. In Figure 2B, the above approach
was repeated for the injection SP,1 as the pair trace.
Since duplicate injections were performed for the five pro-
tein samples including SP, RP, SA, SB, and SC (Figure 1),
there were a total of 10 pair traces to be aligned against the
injection RP,1 as the raw trace. The above procedure was
repeated for the remaining 8 pair traces (data not shown).
As a result, every PCS identified in one or more of the 10
pair injections was interrogated against the raw file of RP,1
to quantify AUL,PCS and AIS,PCS. Each PCS was integrated
over a 1.5-min elution-time window in the RP,1 raw trace,
with a mass tolerance of 10 ppm. After all the PCSs were
determined for AUL,PCS and  AIS,PCS from RP,1, they were
combined. Replicate measurements of a PCS were aver-
aged. AUL,PCS of each PCS quantified in RP,1 was normal-
ized by the sum of AUL,PCS from all the PCSs quantified in
RP,1. Similarly, AIS,PCS of each PCS quantified in RP,1 was
normalized by the sum of AIS,PCS from all the PCSs quan-
tified in RP,1.
The above procedure was repeated for each of the remain-
ing 9 raw traces. In total, 100 pairs of raw trace-pair trace
alignment were done, including the two shown in Figure
2. A total of 10 tables containing the AUL,PCS and AIS,PCS
values for all the identified proteins were generated, with
one table for each injection. Accepted for further interpre-
tation were only the PCSs with no more than one missing
value of either AUL,PCS or AIS,PCS in the 10 injections. Miss-
ing values in AUL,PCS and AIS,PCS were filled by the averaged
minimum  AUL,PCS  value and the averaged minimum
AIS,PCS value from the 10 injections respectively.
Table S1 (Additional file 1) lists the PCS abundance ratios
between SP and RP for all the 1709 detected PCSs. Because
there were duplicate injections for SP and RP, there were
four permuted sample-pairings in total. The PCS abun-
dance ratios were calculated for each permuted sample-
pairing in the UL and IS forms respectively.
Protein relative abundance
A protein relative abundance between a pair of injections
was derived from a PCS abundance ratio between the two
injections in an UL and an IS forms respectively. Specifi-
cally, the PCSs belonging to the same protein were
grouped. The protein relative abundance was estimated
with the average of the PCS abundance ratios of the pro-
tein. A significance of the protein abundance difference
was evaluated by the t-test and the Wilcoxon ranksum test
with built-in functions in Matlab. The function TTEST was
used to evaluate whether the mean of the log-transformed
PCS abundance ratios for a protein was zero. The function
RANKSUM was used to test whether the median of the PCS
abundance ratios for a protein was different from that of
all the PCS abundance ratios in the pair of injections. Both
functions return a p-value and the result of the test at p <
0.05. Table S2 (Additional file 2) shows the protein rela-
tive abundances, the p-values and the results of the t-test
and the Wilcoxon ranksum test for the sample pair SP/RP.
The results in Table S2 were used to determine the pro-
teins with a statistically significant difference in abun-
dance between SP and RP. Hereafter, the term 'significantBMC Bioinformatics 2009, 10:43 http://www.biomedcentral.com/1471-2105/10/43
Page 7 of 18
(page number not for citation purposes)
Base-peak intensity chromatogram alignment Figure 2
Base-peak intensity chromatogram alignment. Two base-peak intensity chromatogram alignments are shown between 
the raw trace RP,1 with the pair traces RP,2 (A) and SP,1 (B) respectively. The alignment was performed with the procedure 
described in reference [21].
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protein' is used with the meaning of 'protein with statisti-
cally significant difference in abundance.'
Significant proteins
Significant proteins were identified by a combination of
three criteria, which included a fold-change, a statistical
test, and a MPSP. For a protein to be identified as differen-
tially expressed, at the least, it needs to meet a fold-change
threshold, and to be tested significant by a statistical test.
Since a protein in the sample pair SP/RP could be evalu-
ated for differential expression with one or more of the
four permuted sample-pairings (Table S1 and Table S2),
the number of permuted sample-pairings in which a pro-
tein was significant could also be used to gauge the statis-
tical significance. The rationale for this criterion is that, if
a protein is tested significant in all four permuted sample-
pairings, it bears more statistical significance than another
protein that is tested significant in fewer permuted sample
parings. Therefore, we use the number of permuted sam-
ple-pairings in which a protein is significant as the third
criterion. This third criterion was in addition to a fold-
change and a statistical test.
For convenience, we use the term MPSP to represent this
third criterion. A MPSP means that a protein would be dif-
ferentially expressed only if it met the fold-change thresh-
old and were found significant by a statistical test in at
least a designated number of permuted sample-pairings.
For the sample pair SP/RP, the MPSP ranges from 1 to 4.
We had several options to perform a statistical test. To
decide the type of a statistical test, we experimented with
both the t-test and the Wilcoxon ranksum test by compar-
ing five options including: a) the t-test alone; b) the Wil-
coxon ranksum test alone; c) either of the two tests,
meaning that a protein was tested significant with at least
one of the two tests; d) both of the two tests, meaning that
a protein was tested significant with both tests; and e) nei-
ther of the two tests, meaning no statistical test was
applied. The results of this experimentation are discussed
later. In the following, the terms 'significant protein' and
'positive' are used interchangeably for the convenience of
describing a FDR.
FDR
Based on the seminal work of Benjamini and Hochberg
[22], a FDR is the expected rate of erroneous rejection of
hypothesis among the total rejected hypothesis. In this
work, the hypothesis is that a protein is not differentially
expressed between the samples SP and RP, in either the UL
or the IS form (Figure 1). The total rejected hypothesis is
the number of differentially expressed UL proteins based
on the UL abundance ratios i.e., RA1,UL, RA2,UL, RA3,UL,
and RA4,UL. These four abundance ratios for the four per-
muted sample-pairings (Figure 1) measured the differen-
tial abundance of the UL proteins between the S and R
cultures. The number of significant UL proteins between
SP and RP reflected the difference between the S and R cul-
tures. Thus, it represented the total rejected hypothesis.
In order to determine the false positives (erroneous rejec-
tion of hypothesis), the same IS protein extract was spiked
into the samples SP and RP. Since the IS proteins were run
under the same procedure for the UL proteins, their abun-
dance in the samples SP and RP were expected to be the
same. Therefore, any IS proteins found significant
between SP and RP based on the IS abundance ratios i.e.,
RA1,IS, RA2,IS, RA3,IS, and RA4,IS, were false positives.
The use of the IS sample to determine the false positives is
analogous to the use of a decoy database to determine
false positives in a database search for peptide identifica-
tions [25,30]. From a decoy database, no peptides are
expected to be positively identified. Similarly, from the IS
sample, no proteins were expected to be differentially
expressed. With a combination of specific thresholds, it
was possible to assign the 'significant' IS proteins as false
positives, and the significant UL proteins as positives. A
FDR was calculated as the ratio between the number of
false positives and the number of positives.
As we briefly discussed previously, neither a fold-change
nor a statistical test alone was sufficient to provide a
desired specificity with a FDR < 5%. Even the combina-
tion of a fold-change and a statistical test was not suffi-
cient to provide the desired specificity. To overcome this
limitation, we introduced the concept of MPSP and used
the combination of a fold-change, a statistical test, and a
MPSP to determine a positive and a false positive.
There were four permutated sample-pairings that formed
the basis of a MPSP. A protein found significant in all four
sample-pairings should bear a higher statistical signifi-
cance than those found significant in fewer permuted
sample-pairings. To determine the significant proteins in
each permuted sample-pairing, a fold-change cutoff was
applied. A statistical test was further applied based on the
multiple detected PCSs for the same protein between the
samples SP and RP. Only if a protein met both the fold-
change and the statistical testing thresholds was it
accepted as a significant protein in the permuted sample-
pairing. Furthermore, only if the protein were found sig-
nificant in at least a designated MPSP e.g., 1, 2, 3, or 4,
would it be accepted as a positive (for an UL protein) or a
false positive (for an IS protein).
We experimented with both the t-test and the Wilcoxon
ranksum test. It is well known that the t-test is more pow-
erful but relies on the assumption that the data is nor-BMC Bioinformatics 2009, 10:43 http://www.biomedcentral.com/1471-2105/10/43
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mally distributed. In contrast, the Wilcoxon ranksum test
does not require any distributional assumption and is
robust but less powerful. We examined the PCS abun-
dance ratios (Table S1) with the Lilliefors test. At a signif-
icance level of 5%, the Lilliefors test rejected the null
hypothesis that the PCS abundance ratios were normally
distributed (data not shown). A further examination of
the PCS abundance ratios in Table S1 with a normal prob-
ability plot, however, revealed that the data followed a
normal distribution approximately between the 15th and
85th percentiles (data not shown). We felt that the t-test
might be appropriate for the data because of its close
approximation to a normal distribution. But, we also
wanted to test whether the Wilcoxon ranksum test would
work better because it does not require any distributional
assumption. Therefore, we examined both statistical tests
in this study. The tests were performed only on the pro-
teins with multiple detected PCSs. The results and the p-
values of the two tests were shown in Table S2 for each
tested protein.
To illustrate how a FDR was calculated using a combina-
tion of the three criteria, we summarized an example of
FDR calculation with the criteria of a 2-fold change, a
MPSP of 4, and the t-test (p < 0.05) in Table 1. The exam-
ple indicates the importance to use a statistical test to con-
trol a FDR. A MPSP is also important to control false
positives. The influence of a fold-change, a statistical test,
and a MPSP on a FDR is further evaluated below.
To facilitate the selection of an optimum combination of
the three criteria, we examined their relationships in Fig-
ure 3 and Figure 4.
We identified the optimum MPSP based on the results in
Figure 3. Figure 3 shows the relationship of a FDR with a
MPSP and a fold-change when the t-test was applied at p
< 0.05. The result indicates that a MPSP has a direct effect
on a FDR. At different levels of fold-change, the FDR
decreased nearly linearly with the increase of a MPSP. At a
MPSP of 4, the FDR was < 0.1 once the fold-change was >
1.5, and reached 0 at a 3-fold change. When the MPSP was
< 4, the FDR remained > 10%. This suggests that a MPSP
of 4 is the optimum threshold. This holds true for other
statistical test options (data not shown).
Table 1: Calculation of FDRs for the sample pair SP/RP
Statistical test option
Proteins Source of significant proteins t-test ranksum either both neither
UL RA1 32 42 44 30 92
RA2 31 38 41 28 99
RA3 29 38 41 26 107
RA4 28 40 41 27 108
MPSP 22 29 29 22 61
IS RA1 91 41 5 8 7 2
RA2 41 01 0 4 5 7
RA3 51 41 4 5 8 4
RA4 51 41 4 5 6 8
MPSP 1 5 5 1 28
FDR 0.045 0.172 0.172 0.045 0.459
FDRs were calculated for the sample pair SP/RP based on a separate quantitation of the UL protein relative abundance and the IS protein relative 
abundance. The fold-change was fixed at 2 and the MPSP at 4. The t-test and the Wilcoxon ranksum test were performed at a 5% significance level. 
RA1, RA2, RA3, and RA4 represent the protein relative abundance for the four permuted sample-pairings. Shown in a row of 'RAx' (x = 1, 2, 3, or 4 
permuted sample-pairings) are the numbers of proteins found significant by the five statistical test options, including: the t-test alone ('t-test'), the 
ranksum test alone ('ranksum'), either the t-test or the ranksum test ('either'), both the t-test and the ranksum test ('both'), and without a statistical 
test ('neither'). Shown in the two 'MPSP' rows are the UL and IS proteins, respectively, found significant in all four permuted sample-pairings. A FDR 
is the ratio of the number of significant IS proteins over the number of significant UL proteins.BMC Bioinformatics 2009, 10:43 http://www.biomedcentral.com/1471-2105/10/43
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Figure 4 shows the effect of different statistical test options
on a FDR. When there was no statistical test (labeled 'nei-
ther' on the 'Statistical test' axis), the FDR remained > 30%
at a fold-change < 5. This level of FDR is not acceptable.
The result demonstrates the need to incorporate a statisti-
cal test to control FDR.
A comparison of all the five statistical test options suggests
that the t-test is the most effective. The t-test alone reduced
the FDR to 0.15 even at a 1-fold change. The FDR quickly
decreased to < 0.10 at a 1.5-fold change, and approached
zero when the fold-change was > 2.5. At a 2-fold change,
the FDR was < 0.05, which was acceptable. The Wilcoxon
ranksum test did not reduce the FDR to < 0.1 even at a 4.5-
fold change. A combination of both the t-test and the Wil-
coxon ranksum test did not show an appreciable improve-
ment to reduce FDR compared to the t-test alone.
In Figure 5, we also examined the effect of a minimum
number of detected PCSs (minPCS) of a protein on FDR.
We performed this analysis based on the expectation that
proteins identified with a higher number of peptides
would be more reliable. If this were critical for a statistical
significance, a minPCS should be included as an addi-
tional criterion. A minPCS means that no proteins with
less than the specified number of detected PCSs should be
considered as significant. Surprisingly, an increasing min-
PCS did not reduce the FDR (Figure 5). Instead, the FDR
increased at a high minPCS. This indicates that eliminat-
ing the proteins with a higher minPCS reduced the
number of positives but not necessarily the number of
false positives. This could be explained by that the t-test
already took into account the contribution of a higher
minPCS. To use a minPCS as a separate criterion was
redundant. Thus, the minPCS is set at 1 by default unless
specified. Since we could only perform the t-test and the
Wilcoxon ranksum test on proteins with a minPCS > 1,
the proteins with 1 PCS were automatically excluded from
the list of significant proteins.
In the following, we describe the use of a receiver operat-
ing characteristic (ROC) analysis [31] to further optimize
the thresholds to identify the differentially expressed pro-
teins between the culture samples S and R.
ROC analysis
Two types of ROC curves can be used [32]. One plots sen-
sitivity versus 1- specificity by varying a threshold. The
Effect of fold-change and MPSP on FDR Figure 3
Effect of fold-change and MPSP on FDR. The t-test was performed at a significance level of 5%. The fold-change varied 
from 1 to 3 with increment by 0.25. The MPSP varied from 1 to 4.BMC Bioinformatics 2009, 10:43 http://www.biomedcentral.com/1471-2105/10/43
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other directly plots the number of true positives (true hits
that meet a threshold cutoff) versus the number of false
positives (false hits that meet a threshold cutoff). We used
the second type of ROC in this study, because it more
intuitively reflects the number of differentially expressed
proteins.
In a statistical analysis of a peptide identification using the
target-decoy database search strategy [25,32-34], true pos-
itives are the claimed correct peptide hits from a genome
database that meet a threshold. False positives are the hits
from a decoy database that meet the same threshold. A
similar principle was applied in this study. In this study,
the true positives were the UL proteins differentially
expressed between SP and RP, and the false positives were
the IS proteins found differentially abundant between SP
and RP. However, we could not realistically validate every
differentially expressed UL proteins as biologically 'true' at
each threshold. Therefore, we chose to call the differen-
tially expressed UL proteins as 'positives' instead of 'true
positives' to avoid confusion. Accordingly, the ROC
curves were plotted as the number of positives versus the
number of false positives, as done in [35]. Since we inter-
rogated the same number of proteins in the UL and IS
forms, a plot of the number of (true) positives versus the
number of false positives was equivalent to a plot of the
(true) positive rate versus the false positive rate, because
the denominator for calculating the rates would have
been the same.
In Figure 6, we used a ROC analysis to compare the detec-
tion sensitivity and specificity of four combinations of a
MPSP, the t-test, and the Wilcoxon ranksum test. In each
panel, the fold-change was adjusted from 1 to 5 with 0.25
increments.
Several features can be seen from Figure 6. First, in all four
cases, the t-test had a lower number of false positives at
the same sensitivity compared to the Wilcoxon ranksum
test. This confirms the above finding that the t-test outper-
Effect of statistical test and fold-change on FDR Figure 4
Effect of statistical test and fold-change on FDR. MPSP was fixed at 4. The fold-change varied from 1 to 5 with 0.25 
increments. With the t-test and the Wilcoxon ranksum test performed at a significance level of 5%, five combinations of the 
two tests were applied as the statistical test criterion: a) without statistical test (neither); b) significant by either the t-test or 
the Wilcoxon ranksum test (either); c) significant by the Wilcoxon ranksum test alone (ranksum); d) significant by the t-test 
alone (t-test); e) significant by both the t-test and the Wilcoxon ranksum test (both).BMC Bioinformatics 2009, 10:43 http://www.biomedcentral.com/1471-2105/10/43
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formed the Wilcoxon ranksum test. Second, the slope of
the ROC curve for the t-test increased from 1.8 in A to 6.0
in D, as estimated with a simple linear regression fit on the
t-test ROC curves (the linear fit curves were not shown).
This suggests that the specificity increased with an increase
of MPSP. Third, each panel had a critical fold-change. At
this critical fold-change, there was an abrupt decrease in
the number of positives, while the number of false posi-
tives remained constant. In each panel, this critical fold-
change is indicated by an arrow and a text label. Interest-
ingly, the number of positives remained relatively consist-
ent at this critical fold-change in all panels, which was 23,
20, 23, and 24 in panels A, B, C, and D respectively. On
the other hand, the number of false positives decreased
from 5 in A to 3 in B, 2 in C, and 1 in D. Thus, the FDR
decreased from 0.22 in A to 0.15 in B, 0.087 in C, and
0.042 in D. These results suggest that the critical fold-
change in each panel was optimum.
The results from the ROC analysis further support that a
combination of a fold-change, the t-test, and a MPSP pro-
vides an effective means to control a FDR. For the samples
SP and RP, we found that the optimum combination of cri-
teria was a 2-fold change, the t-test with p < 0.05, and a
MPSP of 4.
Validation
In order to validate the optimum combination of criteria
for the sample pair SP/RP, we applied those criteria to
additional sample-pairings among the S culture tripli-
cates. The rationale of this validation step is that there
should not be positives when the UL protein abundances
were compared among the S triplicates. Similarly, there
should not be positives when the IS protein abundances
were compared in any sample combination. We tested
whether these notions held true.
We validated the optimum combination of criteria estab-
lished for the sample pair SP/RP by applying it to other
sample-pair combinations (Table 2). Each sample pair
was analyzed by the same set of criteria as for the sample
pair SP/RP. We termed each sample-pair combination a
'sample set'. In each sample set, positives were the pro-
teins differentially expressed in the 'sample' category.
False positives were those found differentially expressed
in the 'control' category.
Effect of minPCS and fold-change on FDR Figure 5
Effect of minPCS and fold-change on FDR. MPSP was fixed at 1. The t-test was applied at a significance level of 5%. The 
fold-change varied from 1 to 5. The minPCS changed from 1 to 8.BMC Bioinformatics 2009, 10:43 http://www.biomedcentral.com/1471-2105/10/43
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Shown in Table 2 are five sample sets in total. Each sample
set was analyzed by the same combination of criteria i.e.,
a 2-fold change, the t-test (p < 0.05), and a MPSP of 4.
When there were more than one sample-pairings in a sam-
ple set, the number of positives and the number of false
positives were respectively averaged. The average FDR was
then calculated.
Sample set I is SP/RP. Since SP and RP were the pooled aver-
age of the triplicates for the cultures S and R respectively,
significant proteins in this sample set represented the dif-
ference between the cultures S and R. The pooling process
took into account possible biological variations by averag-
ing the culture triplicates. The IS proteins accounted for
the variations incurred during sample preparation and
down-stream analysis processes.
Sample set II includes the three sample-pairing combina-
tions among SA, SB, and SC. Any proteins found significant
in the three sample-pairing combinations were ascribed to
the biological variations among the culture triplicates,
and to the variations introduced in sample preparation
and analysis steps.
As expected, the sample pairs SB/SC and SC/SA had a small
number of positives and a small number of false positives.
The sample pair SA/SB had a higher number of positives,
which was not expected. The higher number of positives
in the sample pair SA/SB suggests that there was a statisti-
cally significant difference between SA and SB. Although a
variation was observed among the three samples i.e., SA,
SB, and SC, the three permuted sample pairs among these
three samples contained a significantly smaller number of
positives than the sample pair SP/RP. The average number
of positives in these three sample pairs was 3, which
resulted in a FDR of 0.33. This number of positives was
significantly lower than the 22 positives in the sample pair
SP/RP that resulted in a FDR of 0.045. These data support
the validity of the results in sample set I. A further exami-
nation of positives and false positives with other thresh-
olds (Table S3; Additional file 3) also indicated that SB
and SC were the most similar, whereas SA and SB were the
least similar, consistent with the results shown in Table 2.
ROC analysis Figure 6
ROC analysis. The ROC curves were generated by varying the fold-change threshold from 1 to 5 with 0.25 increments. Pos-
itives and false positives were identified by a combination of three criteria, including a fold-change, a statistical test, and a MPSP. 
The MPSP was fixed at 1, 2, 3, and 4 in panels A, B, C, and D respectively. The t-test (blue curves) and the Wilcoxon ranksum 
test (pink curves) were compared in each panel. Both tests were performed at a significance level of 5%. For the blue curves, 
the arrows indicate an abrupt change in FDR, and the text labels indicate the corresponding fold-change where the abrupt 
change in FDR occurs.BMC Bioinformatics 2009, 10:43 http://www.biomedcentral.com/1471-2105/10/43
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In sample set III, the 'sample' category included the UL
proteins from SP and RP. The 'control' category included
the UL proteins from one of the three sample pairs among
SA, SB, and SC. Apparently, if there were no difference
among the S triplicates, the number of positives and the
FDR would be similar to those in sample set I.
Because the results for sample set II already suggested the
existence of variations among the S triplicates, it was not
surprising that the average FDR for SP/RP increased to 0.14
when a sample pair among the S triplicates was used as a
'control' in sample set III.
Sample set III illustrates the possibility of using replicate
UL protein samples as a 'control'. This would eliminate
the need for an isotopically labeled IS sample. The com-
promise, however, is that the number of LC/MS injections
would be doubled because the 'sample' and the 'control'
need to be run separately.
Sample set IV mirrors sample set III with all the UL pro-
teins swapped by their IS counterparts. Because the same
IS proteins were in the 'sample' and the 'control', no sig-
nificant proteins were expected. As expected, the average
number of positives was 1 that resulted in a FDR of 1.0.
The result supported the methodologies used to identify
positives and false positives.
In sample set V, the 'control' includes the four pairs of
duplicate LC/MS injections for samples SP, SA, SB, and SC.
All the proteins were in the UL form. In such a case, the
'control' only accounts for variations between LC/MS
injections. It does not include variations incurred in sam-
ple preparation prior to a LC/MS analysis.
Not surprisingly, the FDR decreased to zero in sample set
V. Further examination of the FDR for sample set V with
other thresholds indicated that 61 positives could be
called at a zero FDR (Table S3). This was apparently an
overestimation of the number of positives and an under-
estimation of the FDR. The results for other sample sets in
Table 2 clearly indicate that variations were introduced
during sample preparation. Therefore, the use of only LC/
MS injection replicates as 'control' resulted in an overesti-
mation of a statistical significance because it did not take
into account the variations incurred in sample prepara-
Table 2: Validation using different combinations among samples
Validation sample set Sample Control P FP FDR
IS P/RP (UL) SP/RP (IS) 22 1 0.045
II SA/SB (UL) SA/SB (IS) 8 2 -
SB/SC (UL) SB/SC (IS) 0 1 -
SC/SA (UL) SC/SA (IS) 1 0 -
Average 3.0 1.0 0.33
III SP/RP (UL) SA/SB (UL) 22 8 -
SB/SC (UL) 22 0 -
SC/SA (UL) 22 1 -
Average 22 3.0 0.14
IV SP/RP (IS) SA/SB (IS) 1 2 -
SB/SC (IS) 1 1 -
SC/SA (IS) 1 0 -
Average 1.0 1.0 1.0
VS P/RP (UL) Inj.1 vs Inj.2 (UL) of SP, SA, SB, and SC 22 0 0.00
Sample set I represents the target of validation. The parameters used for FDR calculation were: 2-fold change, 4 MPSP, and t-test (p < 0.05). P, 
positives. FP, false positives. '-', not calculated. See text for more details.BMC Bioinformatics 2009, 10:43 http://www.biomedcentral.com/1471-2105/10/43
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tion. This emphasizes the importance to use a 'control'
that consists of sample replicates prepared separately prior
to a LC/MS analysis. The IS samples in sample sets I, II,
and IV met this requirement.
Finally, we compare the results obtained for sample set I
in Table 2 with those obtained in the previous study [6].
The triplicates of the S and R cultures were the same in
both studies. In the previous study, the triplicates were
analyzed individually and the SAM method was used to
identify differentially expressed proteins. A [15N]-labeled
reference sample was used to normalize the abundances
of the unlabeled proteins. An in silico pooled sample was
also generated for the S culture by combining all PCS
abundance ratios of the S triplicates to calculate the aver-
age protein relative abundances. A similar in silico pooled
sample was also generated for the R culture. Protein abun-
dance ratios between the two in silico pooled samples were
calculated to assess the differentially expressed proteins
between the S and R cultures. The in silico pooled sample
pair in the previous study [6] compliments the SP/RP sam-
ple pair in this study (sample set I; Table 2). A pooled
sample in [6] was an in silico averaging of the culture trip-
licates, and a pooled sample in this study was an actual
mixture of the proteins from the culture triplicates (Figure
2). In theory, the pair of pooled samples in both studies
should lead to an identification of the same set of differ-
entially expressed proteins. Because a base-peak intensity
chromatogram alignment and a peptide cross-reference
were performed in this study but not in the previous one,
more proteins were identified in this study (Table S2). We
only compare the proteins common between the pair of
pooled samples in this study and the pair of pooled sam-
ples in the previous study [6].
For the 22 positives identified in this study, 19 were
detected in the previous study [6]. Of the 19 proteins
detected in the previous study, 16 were tested significant
with the t-test and the 2-fold change criterion, and 12
were found significant with the SAM method at a 2-fold
change threshold. All 12 significant proteins between the
S and R cultures identified with the three methods in the
two studies were in agreement in the direction of an abun-
dance change (Table S4; Additional file 4).
Both studies analyzed the center of five SDS/PAGE gel
fractions for each sample. In the previous study, 6 samples
were analyzed in triplicate injections that resulted in a
total of 18 LC/MS injections. A total of 174 proteins were
common in the in silico pooled SP/RP sample pair, and 121
proteins were common among the S and R culture tripli-
cates. In this study, a total of 4 LC/MS injections were car-
ried out for the sample pair SP/RP. With the base-peak
intensity chromatogram alignment and the peptide cross-
reference analysis [21], we quantified 249 proteins with >
1 detected PCSs (Table S2). The method described in this
study is highly effective for exploratory quantitative-pro-
teomics experiments where the number of sample repli-
cates is small.
Conclusion
Using a FDR as an indicator of statistical significance, we
show that a significance analysis can be performed for a
pair of protein samples without replicates with the label-
free quantitative proteomics approach. To perform the
significance analysis, one only needs duplicate LC/MS
injections per sample.
We show that a combination of a fold-change and the t-
test was not sufficient to control a FDR below 5%. We
overcome this limitation by creating permutated sample-
pairings based on duplicate LC/MS injections per sample.
This led us to introduce the concept of MPSP. A MPSP was
used in combination with a fold-change and the t-test to
enhance the specificity. We compared the t-test and the
Wilcoxon ranksum test, and found that the t-test was
more powerful than the Wilcoxon ranksum test even
though the PCS abundance ratios only followed a normal
distribution between approximately 15th and 85th percen-
tiles.
Based on the above observations, we recommend that a
combination of a fold-change, the t-test, and a MPSP
should be used to determine differentially expressed pro-
teins in a label-free quantitative proteomics. For the sam-
ples analyzed in this study, we found that a combination
of a 2-fold change, the t-test (p < 0.05), and a MPSP of 4
was optimum. The results obtained with this combination
of filters agreed well with those in the previous study
where the SAM method was used with more sample repli-
cates [6].
The approach described here would be useful in many
exploratory quantitative-proteomics experiments where a
sample amount or instrument time is limited. In general,
this method would also be suitable for experiments where
multiple replicates of protein sample and LC/MS injection
are available. This method is simple in concept. It is a con-
venient complement to other more sophisticated algo-
rithms that are not designed to deal with a small number
of sample replicates.
Methods
The methods for cell culturing, protein sample prepara-
tion, and peptide and protein identifications were
described previously [6].
Cell culturing
Two unlabeled cultures of M. smegmatis mc2 155 (ATCC;
Rockville, Md) were grown in triplicate in the media pre-BMC Bioinformatics 2009, 10:43 http://www.biomedcentral.com/1471-2105/10/43
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pared with 7H9 base (Sigma; St. Louis, MO) plus 0.05%
Tween80 and 0.2% glucose. One culture was grown at pH
7 (culture R) and the other at pH 5 (culture S). The pH of
the media was adjusted by titrating with 1 M sodium
hydroxide or 2 M hydrochloric acid. One [15N]-labeled
culture was grown as the internal standard (culture IS).
The medium for growing the [15N]-labeled cells consisted
of (g/L) 99At% (15NH4)2SO4: 0.5; glucose: 2; Tween 80:
0.5; citric acid: 0.094; biotin: 0.0005; pyridoxine: 0.001;
NaCl: 0.1; Na2HPO4: 2.5; KH2PO4: 1; MgSO4·6H2O: 0.1;
CuSO4·5H2O: 0.001; ZnSO4·6H2O: 0.002;
CaCl2·2H2O: 0.0007; ferric ammonium citrate: 0.04; pH
5. The cultures were grown at 100 ml in loosely capped
250-ml nephelo culture flasks under shaking at 37°C.
Growth was monitored by measuring turbidity in a
Spec20 spectrometer at 600 nm. The S and R cultures were
harvested at mid-log phase and the IS culture was col-
lected at late-log phase. Thirty milliliters was collected
from each culture replicate and centrifuged at 4000 rpm in
a 5810R refrigerated Eppendorf centrifuge for 10 min at
4°C to pellet the cells.
Sample preparation
Proteins were extracted from the cell pellets by bead beat-
ing using 100 mM ammonium bicarbonate as the extrac-
tion buffer. A protease inhibitor cocktail was added at 1×
as recommended by the manufacturer (Pierce; Rockford,
IL). The cell pellets suspended in the extraction buffer
were vigorously agitated for 2 min at maximum speed in
a Mini-BeadBeater™ (BioSpec, Bartlesville, OK) with 30
sec of ice cooling at the 1-min intermittent. The resultant
mixtures were cleared by centrifugation at 13,000 g at 4°C
for 30 min. The protein concentrations were determined
with a BCA Protein Assay kit (Pierce).
Equal amounts of protein extract from the S culture tripli-
cates were pooled. Equal amounts of protein extract from
the R culture triplicates were also pooled. Into these two
pooled UL protein samples were added an equal amount
of protein extract from the IS culture. This resulted in two
pooled samples which were SP and RP (Figure 1). SP was
the pooled protein extracts from the S culture triplicates
plus the IS protein extract. RP was the pooled protein
extracts from the R culture triplicates plus the IS protein
extract. In addition, the protein extracts of the triplicates
of the S culture were also individually spiked with an
equal amount of the IS protein extract. This resulted in
three additional protein samples which were named SA,
SB, and SC. Altogether, five proteins samples were created
for LC/MS analysis, which were SP, RP, SA, SB, and SC.
The five protein samples were separated on a 5-cm long
10% Tris-HCl SDS-PAGE gel (Pierce) with 100 μg proteins
loaded for each sample. The five gel lanes were revealed by
Imperial Protein Stain (Pierce) and were destained over-
night in water. Each gel lane was divided into 5 fractions
approximately equal in length. Only the 3rd fraction from
each lane was processed for LC/MS analysis. The gel bands
were minced to 1 mm cubes, washed, and processed for
in-gel digestion and peptide extraction [6]. The peptide
extracts were concentrated to near dryness in an Eppen-
dorf Vacufuge concentrator and reconstituted to 25 μl
with 5% formic acid for LC/MS analysis.
LC/MS analysis
We submitted the peptide extracts to the Mass Spectrome-
try Laboratory in the Research Resources Center at Univer-
sity of Illinois at Chicago for analysis on a nano-LC/LTQ-
FTMS system (Thermo Finnigan; San Jose, CA). Each sam-
ple was analyzed in two injections. This resulted in a total
of 10 injections for the 5 protein samples.
In each injection, 5 μl of peptide extract solution was sep-
arated on a 150 mm × 75 μm C18 reverse phase column
with a 5–35% acetonitrile (v/v) gradient in 0.1% TFA over
60 min. The LTQ-FTMS was operated in a data-dependant
acquisition mode with up to 10 MS/MS spectra acquired
following each MS scan. The acquired RAW data files were
searched against the NCBI database of M. smegmatis strain
mc2 155 (downloaded in 2006 with the old locus names)
in two separate BioWorks searches. One search corre-
sponded to [14N] labeling and the other to [15N] labeling.
The precursor ion tolerance was set to ± 1.5 Da. Trypsin
was designated as the digestion enzyme with 2 missed
cleavages allowed. Peptide and protein probabilities were
calculated by BioWorks. Only peptides with p < 0.01 were
accepted for subsequent quantitation of abundance,
which are shown in Table S1. We converted the old locus
names to the new ones using a locus mapping file kindly
provided by Erin Beck of the J. Craig Venter Institute at
Rockville in Maryland. After peptide and protein identifi-
cations, we carried out peptide and protein quantitation
using Matlab v7.2 (MathWorks, Natick, MA) and Micro-
soft Excel based on the previously described methods
[6,16,21].
Figure 1 summarizes, in a flowchart, the six stages to pre-
pare and analyze the protein samples. The six stages, num-
bered from I to VI, are described in the following.
(I) At the cell culturing stage, two M. smegmatis unlabeled
cultures, S and R, were grown in triplicate for label-free
quantitative analysis. S was grown at pH 5, and R was
grown at pH 7. Separately, an internal standard M. smeg-
matis culture IS was grown in a [15N]-labeled medium.
(II) During protein extraction, the triplicates of the unla-
beled cultures S and R were harvested and processed forBMC Bioinformatics 2009, 10:43 http://www.biomedcentral.com/1471-2105/10/43
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protein extraction individually. Aliquots of the triplicate
protein extracts were pooled for the cultures S and R
respectively. Separately, proteins were also extracted from
the IS culture.
(III) To prepare samples for LC/MS analyses, the protein
extract from the IS sample was spiked into the two pooled
samples and the three replicates of culture S. This gener-
ated five protein samples for the LC/MS analyses, which
were labeled as SP, RP, SA, SB, and SC. SA, SB, and SC were
not treated as replicates for differential expression analysis
between the cultures S and R. Instead, they were used for
validation purpose, as described in the main text and in
Table 2. At the remaining stages of IV to VI, the complete
process of analysis was illustrated only for the sample pair
SP/RP. The analyses of the three permuted sample pairs
among SA, SB, and SC were carried out similarly (not
shown in Figure 1), and the results were summarized in
Table 2.
(IV) During the LC/MS analysis, SP and RP were both
injected twice. The resulting four LC/MS injections were
named SP,1, SP,2, RP,1, and RP,2 respectively.
(V) To generate permuted sample-pairings, the four LC/
MS injections were permuted as shown by the arrows. The
permutation resulted in the four sample parings between
SP and RP, which were SP,1/RP,1, SP,1/RP,2, SP,2/RP,1, and SP,2/
RP,2.
(VI) The unlabeled (UL) and labeled (IS) forms of the pro-
teins were independently quantified by the label-free
quantitation method. The UL protein relative abundance
(RAx,UL, x = 1,2,3 or 4) was used to determine the UL pro-
teins differentially expressed between the cultures S and R.
The IS protein relative abundance (RAx,IS, x = 1,2,3 or 4)
was used to determine the IS proteins differentially abun-
dant between the protein samples SP and RP. The differen-
tially expressed UL proteins were positives. The IS proteins
found differentially abundant were false positives. A FDR
was calculated as the ratio of the number of false positives
over the number of positives.
Abbreviations
FDR: false discovery rate; ROC: receiver operating charac-
teristic; MPSP: minimum number of permuted significant
pairings.
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